iBio, Inc.
IBIO
$0.818
$0.0253.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 375.00K | 375.00K | 175.00K | 225.00K | 50.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 375.00K | 375.00K | 175.00K | 225.00K | 50.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 375.00K | 375.00K | 175.00K | 225.00K | 50.00K |
| SG&A Expenses | 10.96M | 10.71M | 10.93M | 11.67M | 11.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.19M | 15.94M | 15.81M | 16.86M | 18.24M |
| Operating Income | -16.81M | -15.56M | -15.64M | -16.63M | -18.19M |
| Income Before Tax | -16.46M | -14.23M | -14.36M | -15.44M | -17.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.46 | -14.23 | -14.36 | -15.44 | -17.13 |
| Earnings from Discontinued Operations | -4.53M | -5.07M | -8.79M | -9.46M | -6.03M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.99M | -19.30M | -23.15M | -24.91M | -23.16M |
| EBIT | -16.81M | -15.56M | -15.64M | -16.63M | -18.19M |
| EBITDA | -16.01M | -14.71M | -14.74M | -15.70M | -17.24M |
| EPS Basic | -2.34 | -2.70 | -6.65 | -10.98 | -17.11 |
| Normalized Basic EPS | -1.13 | -1.44 | -2.65 | -5.01 | -8.36 |
| EPS Diluted | -2.34 | -2.70 | -6.65 | -10.98 | -17.11 |
| Normalized Diluted EPS | -1.13 | -1.44 | -2.65 | -5.01 | -8.36 |
| Average Basic Shares Outstanding | 36.21M | 30.06M | 22.79M | 15.35M | 7.63M |
| Average Diluted Shares Outstanding | 36.21M | 30.06M | 22.79M | 15.35M | 7.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |